Page last updated: 2024-08-18

diatrizoate meglumine and Disease Exacerbation

diatrizoate meglumine has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cohen-Cymberknoh, M; Efrati, O; Fraser, D; Kerem, E; Levy, R; Modan-Moses, D; Nir, J; Rivlin, J; Shoseyov, D; Szeinberg, A; Vilozni, D	1

Other Studies

1 other study(ies) available for diatrizoate meglumine and Disease Exacerbation

Article	Year
Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study. Journal of pediatric gastroenterology and nutrition, 2010, Volume: 50, Issue:2 Topics: Adolescent; Adult; Age Factors; Body Mass Index; Child; Cystic Fibrosis; Diatrizoate Meglumine; Disease Progression; Enema; Female; Humans; Ileus; Infant; Israel; Lung; Male; Meconium; Respiratory Function Tests; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Young Adult	2010

Article

Year

Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study.

Journal of pediatric gastroenterology and nutrition, 2010, Volume: 50, Issue:2

Topics: Adolescent; Adult; Age Factors; Body Mass Index; Child; Cystic Fibrosis; Diatrizoate Meglumine; Disease Progression; Enema; Female; Humans; Ileus; Infant; Israel; Lung; Male; Meconium; Respiratory Function Tests; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Young Adult

2010